Autosomal dominant osteopetrosis
- PMID: 36863500
- PMCID: PMC10042314
- DOI: 10.1016/j.bone.2023.116723
Autosomal dominant osteopetrosis
Abstract
Autosomal dominant osteopetrosis (ADO) is the most common form of osteopetrosis. ADO is characterized by generalized osteosclerosis along with characteristic radiographic features such as a "bone-in-bone" appearance of long bones and sclerosis of the superior and inferior vertebral body endplates. Generalized osteosclerosis in ADO typically results from abnormalities in osteoclast function, due most commonly to mutations in the chloride channel 7 (CLCN7) gene. A variety of debilitating complications can occur over time due to bone fragility, impingement of cranial nerves, encroachment of osteopetrotic bone in the marrow space, and poor bone vascularity. There is a wide spectrum of disease phenotype, even within the same family. Currently, there is no disease specific treatment for ADO, so clinical care focuses on monitoring for disease complications and symptomatic treatment. This review describes the history of ADO, the wide disease phenotype, and potential new therapies.
Keywords: Genes/dominant; Osteopetrosis/epidemiology; Osteopetrosis/genetics; Osteopetrosis/history; Osteopetrosis/pathology; Osteopetrosis/therapy.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest Dr. Econs is a consultant for SiSaf, which is developing a therapy for ADO. Drs. Imel and Polgreen have no relevant conflicts to report.
Figures

References
-
- Bollerslev J, Andersen PE, Radiological, biochemical and hereditary evidence of two types of autosomal dominant osteopetrosis, Bone. 9 (1988) 7–13. - PubMed
-
- Albers-Schonberg H, Rntgenbilder einer seltenen Knochenkrankung, Munchen Med Wochenschr. 51 (1904) 365.
-
- Wu CC, Econs MJ, DiMeglio LA, Insogna KL, Levine MA, Orchard PJ, Miller WP, Petryk A, Rush ET, Shoback DM, Ward LM, Polgreen LE, Diagnosis and Management of Osteopetrosis: Consensus Guidelines from the Osteopetrosis Working Group, J. Clin. Endocrinol. Metab. (2017). 10.1210/jc.2017-01127. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources